Published in Diabetes on June 01, 1986
The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J (1990) 2.83
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J (1997) 2.25
Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A (2004) 1.19
The biochemistry of diabetes. Biochem J (1988) 1.14
Optimized heterologous expression of the human zinc enzyme glyoxalase I. Biochem J (1996) 1.10
Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nat Protoc (2014) 1.10
Technologies for Clinical Diagnosis Using Expired Human Breath Analysis. Diagnostics (Basel) (2015) 1.09
Methylglyoxal, an endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA. Nucleic Acids Res (2001) 1.07
Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. Biochem J (2004) 0.99
Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PLoS One (2012) 0.90
Breath analysis in disease diagnosis: methodological considerations and applications. Metabolites (2014) 0.88
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. Glycoconj J (2016) 0.84
Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism. Autism Res (2011) 0.83
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol (2016) 0.83
Genetics of diabetes complications. Mamm Genome (2014) 0.78
Snakebite mediated acute kidney injury, prognostic predictors, oxidative and carbonyl stress: A prospective study. Indian J Nephrol (2016) 0.77
Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products. PLoS One (2015) 0.77
Enhanced Acetone Sensing Characteristics of ZnO/Graphene Composites. Sensors (Basel) (2016) 0.75
Brain metabolism during fasting. J Clin Invest (1967) 6.48
Hormone-fuel interrelationships during fasting. J Clin Invest (1966) 6.44
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Liver and kidney metabolism during prolonged starvation. J Clin Invest (1969) 3.47
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Human forearm metabolism during progressive starvation. J Clin Invest (1971) 1.52
Reassessment of body mass indices. Am J Clin Nutr (1990) 1.51
Plasma acetate turnover and oxidation. J Clin Invest (1979) 1.47
Somatostatin suppresses secretin and pancreatic exocrine secretion. Science (1975) 1.45
Altered glucose metabolism in metastatic carcinoma. Cancer Res (1975) 1.43
Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med (1982) 1.41
A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc Natl Acad Sci U S A (1994) 1.39
Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest (1974) 1.37
A reappraisal of caloric requirements in healthy women. Am J Clin Nutr (1986) 1.35
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med (1981) 1.30
Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes (1981) 1.25
Energy metabolism in feasting and fasting. Adv Exp Med Biol (1979) 1.24
Plasma acetone metabolism in the fasting human. J Clin Invest (1979) 1.21
Thermic effect of food in lean and obese men. J Clin Invest (1988) 1.18
Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control. Diabetes (1983) 1.18
Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J Clin Invest (1973) 1.15
Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes (1988) 1.14
Effects of intraduodenal amino acids, fatty acids, and sugars on secretin concentrations. Gastroenterology (1975) 1.12
Starvation and survival. Trans Am Clin Climatol Assoc (1968) 1.09
Ketosis of starvation: a revisit and new perspectives. Clin Endocrinol Metab (1983) 1.08
Effects of short- and long-term administration of pentazocine in man. Clin Pharmacol Ther (1970) 1.07
Nitrogen sparing induced by a mixture of essential amino acids given chiefly as their keto-analogues during prolonged starvation in obese subjects. J Clin Invest (1974) 1.06
Development and regulation of lipid synthesis from ketone bodies by rat brain. J Neurochem (1977) 1.06
Ketone-body production and oxidation in fasting obese humans. J Clin Invest (1974) 1.06
Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes (1980) 1.02
The consumption of fuels during prolonged starvation. Adv Enzyme Regul (1968) 1.02
Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest (1981) 1.00
Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol. J Mol Cell Cardiol (1998) 1.00
Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J Clin Invest (1988) 1.00
Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res (1984) 0.99
Renal conservation of ketone bodies during starvation. Metabolism (1975) 0.99
Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations. J Clin Invest (1974) 0.97
Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet (1986) 0.96
Acetone metabolism during diabetic ketoacidosis. Diabetes (1982) 0.96
Prevention of postprandial hypotension with somatostatin. Ann Intern Med (1985) 0.96
In vivo and in vitro effects of antiinsulin receptor antibodies. J Clin Endocrinol Metab (1984) 0.95
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med (1986) 0.95
Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin. Ann Intern Med (1980) 0.95
Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest (1983) 0.94
Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest (1973) 0.94
Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts. Ann Surg (1979) 0.91
Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr (1983) 0.91
Lipogenesis from ketone bodies in rat brain. Evidence for conversion of acetoacetate into acetyl-coenzyme A in the cytosol. Biochem J (1976) 0.90
Substrate, hormone, and temperature responses in males and females to a common breakfast. Metabolism (1980) 0.90
Acid hydrolysis of urinary catecholamines. J Lab Clin Med (1970) 0.90
Fatty acid synthesis by human adipose tissue. Metabolism (1975) 0.90
Assessment of norepinephrine secretion and production. J Lab Clin Med (1983) 0.89
The metabolism of ketone bodies in developing human brain: development of ketone-body-utilizing enzymes and ketone bodies as precursors for lipid synthesis. J Neurochem (1975) 0.88
Effects of glucagon on plasma amino acids. J Clin Invest (1984) 0.88
Lactate metabolism in patients with metastatic colorectal cancer. Cancer Res (1979) 0.88
Blood glucose and cluconeogenesis in fasting man. Arch Intern Med (1969) 0.88
Human splanchnic metabolism during diabetic ketoacidosis. Metabolism (1977) 0.87
General metabolic abnormalities in cancer patients: anorexia and cachexia. Surg Clin North Am (1986) 0.87
Kynurenic acid and xanthurenic acid excretion after tryptophan loading in actinic reticuloid. Int J Dermatol (1987) 0.86
Managing insulin-dependent diabetic patients. Postgrad Med (1976) 0.86
Treatment of orthostatic hypotension with dihydroergotamine and caffeine. Ann Intern Med (1986) 0.86
Increased osmolal gap in alcoholic acidosis. Arch Intern Med (1993) 0.86
The effect of carbohydrates on ammonium and ketoacid excretion during starvation. J Clin Invest (1972) 0.85
Effect of hyperphenylalaninaemia on lipid synthesis from ketone bodies by rat brain. Biochem J (1976) 0.85
Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism (1974) 0.84
Familial hyperglucagonemia--an autosomal dominant disorder. N Engl J Med (1977) 0.84
Role of substrate in the regulation of hepatic gluconeogenesis in fasting man. Adv Enzyme Regul (1969) 0.83
Utilization of metabolic fuels in obese subjects. Am J Clin Nutr (1968) 0.83
Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. J Clin Invest (1980) 0.83
Ketone body metabolism in normal, obese and diabetic subjects. Isr J Med Sci (1975) 0.83
Effects of aging on catecholamine metabolism. J Clin Endocrinol Metab (1985) 0.82
Immunological potency and stability of native and synthetic secretins. Gastroenterology (1974) 0.82
Role of glucagon in disposal of an amino acid load. Am J Physiol (1990) 0.82